WHO ICTRP trial
Atellica VTLi Sample matrix study for Plasma Separation Membrane Comparison
NL-OMON51710 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON51710 |
|---|---|
| Public title | Atellica VTLi Sample matrix study for Plasma Separation Membrane Comparison |
| Scientific title | Atellica VTLi Sample matrix study for Plasma Separation Membrane Comparison - Atellica VTLi Plasma separation Membrane Comparison |
| Primary sponsor | Siemens Healthineers |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Observational invasive |
| Countries | The Netherlands |
| Conditions | heart attack Myocardial Infarction;10082206;heart attack;Myocardial Infarction |
| Interventions | ;Atellica VTLi;Plasma separation membrane |
| Registration date | Oct 11, 2022 |
| Target size | 100 |
| Secondary IDs | NL81218.075.22 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: